BNP PARIBAS FINANCIAL MARKETS - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 42 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$49,965
+41.7%
12,861
+110.5%
0.00%
Q2 2023$35,255
+769.2%
6,110
+879.2%
0.00%
Q1 2023$4,056
+6.6%
624
-54.9%
0.00%
Q4 2022$3,806
-99.7%
1,384
+171.4%
0.00%
Q3 2022$1,489,000
-93.9%
510
-96.0%
0.00%
Q2 2022$24,342,000
+149.9%
12,678
+955.6%
0.00%
Q1 2022$9,740,000
-76.3%
1,201
-73.2%
0.00%
Q4 2021$41,119,000
+27.5%
4,489
+74.1%
0.00%
Q3 2021$32,238,000
+350.7%
2,579
+307.4%
0.00%
Q2 2021$7,153,000
-73.3%
633
-64.2%
0.00%
Q1 2021$26,816,000
-17.6%
1,770
-37.4%
0.00%
Q4 2020$32,539,000
+27.5%
2,827
-14.3%
0.00%
Q3 2020$25,527,000
+223.8%
3,298
+360.6%
0.00%
Q2 2020$7,883,000
-82.0%
716
-82.2%
0.00%
Q1 2020$43,906,000
+6.1%
4,017
+54.2%
0.00%
Q4 2019$41,393,000
+50.9%
2,605
+40.1%
0.00%
Q3 2019$27,439,000
+49.2%
1,859
+17.4%
0.00%
Q2 2019$18,394,000
-24.7%
1,583
-30.0%
0.00%
Q1 2019$24,441,000
+101737.5%
2,261
+75266.7%
0.00%
Q4 2018$24,00030.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Perceptive Advisors 5,038,983$29,074,9310.84%
BML Capital Management, LLC 150,000$865,5000.78%
Avoro Capital Advisors LLC 2,954,064$17,044,9490.23%
SteelPeak Wealth, LLC 135,361$781,0330.05%
Legacy Trust 18,750$108,1880.03%
GSA CAPITAL PARTNERS LLP 38,168$2200.02%
Miracle Mile Advisors, LLC 118,221$682,1350.02%
SPC Financial, Inc. 30,000$173,1000.02%
KORNITZER CAPITAL MANAGEMENT INC /KS 129,251$745,7780.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 74,550$430,1540.01%
View complete list of VERRICA PHARMACEUTICALS INC shareholders